Cyclenium Pharma Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Cyclenium Pharma General Information
Description
Operator of a biotechnology company intended to conduct research and development for drug discovery. The company aims at exploiting its next-generation CMRT macrocyclic drug discovery technology to identify novel small molecule therapeutics for difficult disease targets in areas of unsatisfied medical need, enabling doctors to find useful and innovative drugs for not-so-common diseases.
Contact Information
Website
www.cyclenium.com(Operating Subsidiary)
Corporate Office
- 7171 Frederick Banting
- Montreal, Quebec H4S 1Z9
- Canada
Corporate Office
- 7171 Frederick Banting
- Montreal, Quebec H4S 1Z9
- Canada
Cyclenium Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Cyclenium Pharma Comparisons
Industry
Financing
Details
Cyclenium Pharma Competitors (55)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Vividion Therapeutics | Formerly VC-backed | San Diego, CA | 000 | 00000 | 00000000 | |
Circle Pharma | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 00000000000 | 00000 |
CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
NexImmune | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
Protagonist Therapeutics | Formerly VC-backed | Newark, CA | 000 | 00000 | 00000000 | 00000 |
Cyclenium Pharma Patents
Cyclenium Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200190083-A1 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Pending | 22-Jun-2017 | 0000000000 | |
EP-3642399-A4 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Inactive | 22-Jun-2017 | 0000000000 | 0 |
EP-3642399-A1 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Inactive | 22-Jun-2017 | 0000000000 | |
CA-3066499-A1 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Pending | 22-Jun-2017 | 0000000000 | |
EP-3458630-A4 | Libraries of diverse macrocyclic compounds and methods of making and using the same | Inactive | 16-May-2016 | C40B30/06 |
Cyclenium Pharma Executive Team (2)
Name | Title | Board Seat |
---|---|---|
Helmut Thomas Ph.D | Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Advisor | |
Mark Peterson Ph.D | Co-Founder, Chief Operating Officer, Corporate Secretary & Board Member |
Cyclenium Pharma Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000 00000000 00.0 | Cyclenium Pharma | Co-Founder, Chief Operating Officer, Corporate Secretary & Board Member | 000 0000 |
Cyclenium Pharma Signals
Cyclenium Pharma FAQs
-
When was Cyclenium Pharma founded?
Cyclenium Pharma was founded in 2013.
-
Who is the founder of Cyclenium Pharma?
Helmut Thomas Ph.D and Mark Peterson Ph.D are the founders of Cyclenium Pharma.
-
Who is the CEO of Cyclenium Pharma?
Helmut Thomas Ph.D is the CEO of Cyclenium Pharma.
-
Where is Cyclenium Pharma headquartered?
Cyclenium Pharma is headquartered in Montreal, Canada.
-
What is the size of Cyclenium Pharma?
Cyclenium Pharma has 7 total employees.
-
What industry is Cyclenium Pharma in?
Cyclenium Pharma’s primary industry is Biotechnology.
-
Is Cyclenium Pharma a private or public company?
Cyclenium Pharma is a Private company.
-
What is Cyclenium Pharma’s current revenue?
The current revenue for Cyclenium Pharma is 000000.
-
Who are Cyclenium Pharma’s competitors?
Vividion Therapeutics, Circle Pharma, CytomX Therapeutics, NexImmune, and Protagonist Therapeutics are some of the 55 competitors of Cyclenium Pharma.
-
When was Cyclenium Pharma acquired?
Cyclenium Pharma was acquired on 06-Jun-2023.
-
Who acquired Cyclenium Pharma?
Cyclenium Pharma was acquired by SpiroChem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »